{"id":"https://openalex.org/W1993742630","doi":"https://doi.org/10.1038/sj.bjp.0703989","title":"Dose\u2010related neuroprotective effects of chronic nicotine in 6\u2010hydroxydopamine treated rats, and loss of neuroprotection in \u03b14 nicotinic receptor subunit knockout mice","display_name":"Dose\u2010related neuroprotective effects of chronic nicotine in 6\u2010hydroxydopamine treated rats, and loss of neuroprotection in \u03b14 nicotinic receptor subunit knockout mice","publication_year":2001,"publication_date":"2001-04-01","ids":{"openalex":"https://openalex.org/W1993742630","doi":"https://doi.org/10.1038/sj.bjp.0703989","mag":"1993742630","pmid":"https://pubmed.ncbi.nlm.nih.gov/11309235","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/1572727"},"language":"en","primary_location":{"id":"doi:10.1038/sj.bjp.0703989","doi":"https://doi.org/10.1038/sj.bjp.0703989","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0703989","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0703989","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"bronze","oa_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0703989","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"R E Ryan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":true,"raw_author_name":"R E Ryan","raw_affiliation_strings":["Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia. rebecca.ryan@vcp.monash.edu.au","Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy (Monash University), Parkville, Victoria 3052, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia. rebecca.ryan@vcp.monash.edu.au","institution_ids":["https://openalex.org/I56590836"]},{"raw_affiliation_string":"Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy (Monash University), Parkville, Victoria 3052, Australia","institution_ids":["https://openalex.org/I56590836"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5052081807","display_name":"Shelley A. Ross","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I2801350665","display_name":"Monash Medical Centre","ror":"https://ror.org/036s9kg65","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801350665","https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"S A Ross","raw_affiliation_strings":["Department of Medicine, Monash Medical Centre, Clayton Road, Clayton, Victoria 3168, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Monash Medical Centre, Clayton Road, Clayton, Victoria 3168, Australia","institution_ids":["https://openalex.org/I2801350665"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5081124038","display_name":"John Drago","orcid":"https://orcid.org/0000-0003-0335-1562","observed_orcids":["https://orcid.org/0000-0003-0335-1562"]},"institutions":[{"id":"https://openalex.org/I2801350665","display_name":"Monash Medical Centre","ror":"https://ror.org/036s9kg65","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2801350665","https://openalex.org/I4210121067"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"J Drago","raw_affiliation_strings":["Department of Medicine, Monash Medical Centre, Clayton Road, Clayton, Victoria 3168, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Medicine, Monash Medical Centre, Clayton Road, Clayton, Victoria 3168, Australia","institution_ids":["https://openalex.org/I2801350665"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5056899194","display_name":"Richard E. Loiacono","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I56590836","display_name":"Monash University","ror":"https://ror.org/02bfwt286","country_code":"AU","type":"education","lineage":["https://openalex.org/I56590836"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"R E Loiacono","raw_affiliation_strings":["Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Pharmaceutical Biology and Pharmacology, Victorian College of Pharmacy, Monash University, Parkville, Victoria 3052, Australia","institution_ids":["https://openalex.org/I56590836"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":[],"corresponding_institution_ids":["https://openalex.org/I56590836"],"apc_list":{"value":4780,"currency":"USD","value_usd":4780},"apc_paid":null,"fwci":9.188,"has_fulltext":true,"cited_by_count":186,"citation_normalized_percentile":{"value":0.98626637,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":99},"biblio":{"volume":"132","issue":"8","first_page":"1650","last_page":"1656"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10085","display_name":"Parkinson's Disease Mechanisms and Treatments","score":0.8241999745368958,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11818","display_name":"Nicotinic Acetylcholine Receptors Study","score":0.15860000252723694,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T13991","display_name":"Nuclear Receptors and Signaling","score":0.003599999938160181,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/nicotine","display_name":"nicotine","score":0.859000027179718},{"id":"https://openalex.org/keywords/neuroprotection","display_name":"neuroprotection","score":0.9829999804496765},{"id":"https://openalex.org/keywords/6-hydroxydopamine","display_name":"6-hydroxydopamine","score":0.8970000147819519},{"id":"https://openalex.org/keywords/methamphetamine","display_name":"methamphetamine","score":0.7009999752044678},{"id":"https://openalex.org/keywords/striatal-dopaminergic-neurons","display_name":"striatal dopaminergic neurons","score":0.7929999828338623},{"id":"https://openalex.org/keywords/parkinson-s-disease","display_name":"Parkinson's disease","score":0.6320000290870667},{"id":"https://openalex.org/keywords/receptor-desensitization","display_name":"receptor desensitization","score":0.765999972820282},{"id":"https://openalex.org/keywords/dose-dependent-effects","display_name":"dose-dependent effects","score":0.628000020980835},{"id":"https://openalex.org/keywords/knockout-mice","display_name":"knockout mice","score":0.4959999918937683},{"id":"https://openalex.org/keywords/neurodegeneration","display_name":"neurodegeneration","score":0.621999979019165}],"concepts":[{"id":"https://openalex.org/C25498285","wikidata":"https://www.wikidata.org/wiki/Q1981368","display_name":"Neuroprotection","level":2,"score":0.8819365501403809},{"id":"https://openalex.org/C2779547902","wikidata":"https://www.wikidata.org/wiki/Q28086552","display_name":"Nicotine","level":2,"score":0.7411812543869019},{"id":"https://openalex.org/C2776925932","wikidata":"https://www.wikidata.org/wiki/Q1755122","display_name":"Neurodegeneration","level":3,"score":0.726421058177948},{"id":"https://openalex.org/C137183658","wikidata":"https://www.wikidata.org/wiki/Q461076","display_name":"Dopaminergic","level":3,"score":0.6563194990158081},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.6456867456436157},{"id":"https://openalex.org/C188987157","wikidata":"https://www.wikidata.org/wiki/Q7030581","display_name":"Nicotinic agonist","level":3,"score":0.5478687882423401},{"id":"https://openalex.org/C2780376393","wikidata":"https://www.wikidata.org/wiki/Q191924","display_name":"Methamphetamine","level":2,"score":0.5162767767906189},{"id":"https://openalex.org/C2779570518","wikidata":"https://www.wikidata.org/wiki/Q412256","display_name":"Nicotinic acetylcholine receptor","level":4,"score":0.4925402104854584},{"id":"https://openalex.org/C2911016594","wikidata":"https://www.wikidata.org/wiki/Q15946111","display_name":"Hydroxydopamine","level":4,"score":0.4891946315765381},{"id":"https://openalex.org/C182704531","wikidata":"https://www.wikidata.org/wiki/Q1364740","display_name":"Knockout mouse","level":3,"score":0.4219481348991394},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.39405614137649536},{"id":"https://openalex.org/C513476851","wikidata":"https://www.wikidata.org/wiki/Q170304","display_name":"Dopamine","level":2,"score":0.38074007630348206},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.3741772770881653},{"id":"https://openalex.org/C185592680","wikidata":"https://www.wikidata.org/wiki/Q2329","display_name":"Chemistry","level":0,"score":0.35547834634780884},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35070082545280457},{"id":"https://openalex.org/C170493617","wikidata":"https://www.wikidata.org/wiki/Q208467","display_name":"Receptor","level":2,"score":0.2796974182128906},{"id":"https://openalex.org/C2779134260","wikidata":"https://www.wikidata.org/wiki/Q12136","display_name":"Disease","level":2,"score":0.0}],"mesh":[{"descriptor_ui":"D000818","descriptor_name":"Animals","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D004298","descriptor_name":"Dopamine","qualifier_ui":"Q000502","qualifier_name":"physiology","is_major_topic":false},{"descriptor_ui":"D004305","descriptor_name":"Dose-Response Relationship, Drug","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006892","descriptor_name":"Hydroxydopamines","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D008694","descriptor_name":"Methamphetamine","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D009411","descriptor_name":"Nerve Endings","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D009538","descriptor_name":"Nicotine","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000187","qualifier_name":"drug effects","is_major_topic":false},{"descriptor_ui":"D011978","descriptor_name":"Receptors, Nicotinic","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":true},{"descriptor_ui":"D013563","descriptor_name":"Sympathectomy, Chemical","qualifier_ui":null,"qualifier_name":null,"is_major_topic":true},{"descriptor_ui":"D017207","descriptor_name":"Rats, Sprague-Dawley","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018345","descriptor_name":"Mice, Knockout","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018696","descriptor_name":"Neuroprotective Agents","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018722","descriptor_name":"Nicotinic Agonists","qualifier_ui":"Q000494","qualifier_name":"pharmacology","is_major_topic":true},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000037","qualifier_name":"antagonists & inhibitors","is_major_topic":false},{"descriptor_ui":"D018765","descriptor_name":"Dopamine Uptake Inhibitors","qualifier_ui":"Q000633","qualifier_name":"toxicity","is_major_topic":false},{"descriptor_ui":"D051379","descriptor_name":"Mice","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D051381","descriptor_name":"Rats","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":3,"locations":[{"id":"doi:10.1038/sj.bjp.0703989","doi":"https://doi.org/10.1038/sj.bjp.0703989","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0703989","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0703989","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:1572727","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/1572727","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Br J Pharmacol","raw_type":"Text"},{"id":"pmid:11309235","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/11309235","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British journal of pharmacology","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1038/sj.bjp.0703989","doi":"https://doi.org/10.1038/sj.bjp.0703989","is_oa":true,"landing_page_url":"https://doi.org/10.1038/sj.bjp.0703989","pdf_url":"https://onlinelibrary.wiley.com/doi/pdfdirect/10.1038/sj.bjp.0703989","source":{"id":"https://openalex.org/S55107261","display_name":"British Journal of Pharmacology","issn_l":"0007-1188","issn":["0007-1188","1476-5381"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"British Journal of Pharmacology","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9763000011444092,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[{"id":"https://openalex.org/F4320320971","display_name":"Monash University","ror":"https://ror.org/02bfwt286"},{"id":"https://openalex.org/F4320320974","display_name":"University of Melbourne","ror":"https://ror.org/01ej9dk98"},{"id":"https://openalex.org/F4320334626","display_name":"Medical Research Council","ror":"https://ror.org/03x94j517"},{"id":"https://openalex.org/F4320334705","display_name":"National Health and Medical Research Council","ror":"https://ror.org/011kf5r70"}],"has_content":{"pdf":true,"grobid_xml":true},"content_urls":{"pdf":"https://content.openalex.org/works/W1993742630.pdf","grobid_xml":"https://content.openalex.org/works/W1993742630.grobid-xml"},"referenced_works_count":50,"referenced_works":["https://openalex.org/W364740323","https://openalex.org/W1544301323","https://openalex.org/W1581931593","https://openalex.org/W1908660545","https://openalex.org/W1946523045","https://openalex.org/W1967727191","https://openalex.org/W1967773964","https://openalex.org/W1979858404","https://openalex.org/W1985313555","https://openalex.org/W1987446689","https://openalex.org/W1989771432","https://openalex.org/W1991888228","https://openalex.org/W1997284445","https://openalex.org/W2001775202","https://openalex.org/W2005274709","https://openalex.org/W2005693430","https://openalex.org/W2009642582","https://openalex.org/W2016087905","https://openalex.org/W2018154493","https://openalex.org/W2020846299","https://openalex.org/W2021839841","https://openalex.org/W2029246446","https://openalex.org/W2030003339","https://openalex.org/W2041566830","https://openalex.org/W2042639976","https://openalex.org/W2044779910","https://openalex.org/W2045101766","https://openalex.org/W2045992463","https://openalex.org/W2047632293","https://openalex.org/W2049774481","https://openalex.org/W2057738698","https://openalex.org/W2065000444","https://openalex.org/W2080357105","https://openalex.org/W2081391428","https://openalex.org/W2081935822","https://openalex.org/W2084285811","https://openalex.org/W2087199848","https://openalex.org/W2090080756","https://openalex.org/W2090796082","https://openalex.org/W2093407012","https://openalex.org/W2094391020","https://openalex.org/W2109223175","https://openalex.org/W2143959688","https://openalex.org/W2163815564","https://openalex.org/W2171584675","https://openalex.org/W2228073141","https://openalex.org/W2259962654","https://openalex.org/W2322463045","https://openalex.org/W2415485176","https://openalex.org/W4320577279"],"related_works":["https://openalex.org/W7073766313","https://openalex.org/W1742588512","https://openalex.org/W2369979866","https://openalex.org/W2194030168","https://openalex.org/W7128906106","https://openalex.org/W2023903683","https://openalex.org/W2097894700","https://openalex.org/W1975598998","https://openalex.org/W2073036947","https://openalex.org/W2116550894"],"abstract_inverted_index":{"The":[0,219],"present":[1],"study":[2],"examined":[3],"the":[4,41,195,236],"effect":[5,184,238],"of":[6,9,11,43,80,84,151,171,197,203,226,235,239],"a":[7,232],"range":[8],"doses":[10,62,137,202],"chronic":[12,96],"nicotine":[13,45,97,136,146,161,189,204,240],"(0.75,":[14],"1.5,":[15],"3.0":[16],"and":[17,40,69,114,122,131,191],"30.0":[18,132],"mg":[19,47,58,124,133],"kg(-1)":[20,125,134],"day(-1),":[21],"s.c.,":[22],"14":[23],"days)":[24],"upon":[25,51,188,241],"striatal":[26,52,85],"dopaminergic":[27,86,173],"nerve":[28,87],"terminal":[29],"survival":[30],"following":[31],"6-hydroxydopamine":[32],"(6-OHDA;":[33],"10":[34],"microg":[35],"intrastriatal":[36,109],"unilaterally)":[37],"in":[38,67,178,213,244],"rats;":[39],"effects":[42],"acute":[44,145,160],"(1":[46],"kg(-1),":[48,59],"s.c.)":[49],"pretreatment":[50],"neurodegeneration":[53,177],"induced":[54],"by":[55,91,100],"methamphetamine":[56],"(5":[57],"i.p.,":[60],"three":[61],"at":[63],"2":[64],"h":[65],"intervals)":[66],"wild-type":[68,143],"alpha4":[70,155,214,227],"nicotinic":[71],"receptor":[72],"(nAChR)":[73],"subunit":[74,157,216,228],"knockout":[75,158,217],"mice.":[76,218],"In":[77,94,142,154,180],"both":[78],"models":[79],"Parkinsonian-like":[81,176,242],"damage,":[82],"loss":[83],"terminals":[88],"was":[89],"assessed":[90],"[(3)H]-mazindol":[92],"autoradiography.":[93],"rats,":[95,181],"infusion":[98],"delivered":[99],"osmotic":[101],"minipump":[102],"implanted":[103],"subcutaneously":[104],"7":[105],"days":[106],"prior":[107],"to":[108,164,206],"6-OHDA":[110],"injection":[111],"produced":[112,148],"significant":[113,149],"dose-related":[115],"protection":[116],"against":[117,175],"6-OHDA-induced":[118,140],"neurodegeneration.":[119,153,167],"Low":[120],"(0.75":[121],"1.5":[123],"day(-1))":[126,135],"but":[127],"not":[128],"high":[129],"(3.0":[130],"significantly":[138],"inhibited":[139],"degeneration.":[141],"mice,":[144,159],"treatment":[147,162],"inhibition":[150],"methamphetamine-induced":[152,166],"nAChR":[156,215],"failed":[163],"inhibit":[165],"Nicotine":[168],"is":[169,185,192,211],"capable":[170],"protecting":[172],"neurons":[174],"vivo.":[179,245],"this":[182],"neuroprotective":[183,237],"critically":[186],"dependent":[187],"dose":[190],"consistent":[193],"with":[194],"activation":[196,225],"nAChRs,":[198],"as":[199],"high,":[200],"desensitizing":[201],"fail":[205],"be":[207],"neuroprotective.":[208],"Further,":[209],"neuroprotection":[210],"absent":[212],"current":[220],"results":[221],"therefore":[222],"suggest":[223],"that":[224],"containing":[229],"nAChRs":[230],"constitutes":[231],"major":[233],"component":[234],"damage":[243]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":4},{"year":2024,"cited_by_count":1},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":7},{"year":2020,"cited_by_count":8},{"year":2019,"cited_by_count":5},{"year":2018,"cited_by_count":7},{"year":2017,"cited_by_count":3},{"year":2016,"cited_by_count":8},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":8},{"year":2013,"cited_by_count":7},{"year":2012,"cited_by_count":5}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}